menu-iconMore mobile-close-icon
Skip Navigation
Skip Navigation
Home
Browse Guidelines
Expert Commentaries
Guideline Syntheses
Guideline Matrix
Guideline Resources
Compare Guidelines
Frequently Asked Questions
Submit Guidelines
About
myNGC
Search within:  

Sort results by:      



Filter results by:

1-20 of 23   Next >
 
1.  
Guidelines for the first line management of classical Hodgkin lymphoma. 2014 Jul. NGC:010295
British Committee for Standards in Haematology - Professional Association. View all guidelines by the developer(s)
2.  
British HIV Association guidelines for HIV-associated malignancies 2014. 2008 (revised 2014 Mar). NGC:010275
British HIV Association - Disease Specific Society. View all guidelines by the developer(s)
3.  
Guidelines for the management of mature T-cell and NK-cell neoplasms (excluding cutaneous T-cell lymphoma). 2011 May (revised 2013 Aug). NGC:010000
British Committee for Standards in Haematology - Professional Association. View all guidelines by the developer(s)
4.  
Chronic lymphocytic leukemia. 2010 May (revised 2013 Mar). NGC:010276
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
5.  
Guidelines for the diagnosis and management of multiple myeloma 2013. 2006 Feb (revised 2013). NGC:010002
British Committee for Standards in Haematology - Professional Association. View all guidelines by the developer(s)
6.  
British Association of Dermatologists' guidelines for the management of bullous pemphigoid 2012. 2002 Aug (revised 2012 Dec). NGC:009483
British Association of Dermatologists - Medical Specialty Society. View all guidelines by the developer(s)
8.  
9.  
KDIGO clinical practice guideline for glomerulonephritis. 2012 Jun. NGC:009271
Kidney Disease: Improving Global Outcomes - Nonprofit Organization. View all guidelines by the developer(s)
10.  
11.  
Guidelines on the diagnosis, investigation and management of chronic lymphocytic leukaemia. 2004 May (revised 2012). NGC:009278
British Committee for Standards in Haematology - Professional Association. View all guidelines by the developer(s)
12.  
Update of the clinical practice guideline for the management of rheumatoid arthritis in Spain. 2001 (revised 2011 Dec). NGC:009044
Advanced Research Techniques in the Health Services - For Profit Research Organization; Spanish Society of Rheumatology - Medical Specialty Society. View all guidelines by the developer(s)
13.  
Multifocal motor neuropathy. 2006 Mar (revised 2011). NGC:008775
European Federation of Neurological Societies - Medical Specialty Society. View all guidelines by the developer(s)
14.  
Paraproteinaemic demyelinating neuropathies. 2006 Mar (revised 2011). NGC:008786
European Federation of Neurological Societies - Medical Specialty Society. View all guidelines by the developer(s)
15.  
Guidelines for treatment of autoimmune neuromuscular transmission disorders. 2006 Jul (revised 2010 Jul). NGC:007905
European Federation of Neurological Societies - Medical Specialty Society. View all guidelines by the developer(s)
16.  
Rituximab for the treatment of relapsed or refractory chronic lymphocytic leukaemia. 2010 Jul. NGC:008068
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
17.  
ACR Appropriateness Criteria® Hodgkin's lymphoma--stage III and IV. 1999 (revised 2010). NGC:008471
American College of Radiology - Medical Specialty Society. View all guidelines by the developer(s)
18.  
Rituximab in chronic lymphocytic leukemia. 2009 Nov 18. NGC:007886
Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
19.  
Rituximab for the first-line treatment of chronic lymphocytic leukaemia. 2009 Jul. NGC:007689
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
20.  
Diagnosis, management, and treatment of hepatitis C: an update. 2004 Apr (revised 2009 Apr). NGC:007278
American Association for the Study of Liver Diseases - Nonprofit Research Organization. View all guidelines by the developer(s)
1-20 of 23   Next >